FY2017 EPS Estimates for Smith & Nephew plc Reduced by Northcoast Research (NYSE:SNN)

Smith & Nephew plc (NYSE:SNN) – Research analysts at Northcoast Research reduced their FY2017 earnings estimates for shares of Smith & Nephew in a research note issued to investors on Friday, according to Zacks Investment Research. Northcoast Research analyst D. Keiser now expects that the medical equipment provider will post earnings per share of $1.79 for the year, down from their prior forecast of $1.81. Northcoast Research also issued estimates for Smith & Nephew’s Q4 2017 earnings at $0.93 EPS and FY2018 earnings at $1.85 EPS.

Other equities analysts have also issued reports about the company. Canaccord Genuity assumed coverage on Smith & Nephew in a research report on Wednesday, October 11th. They set a “buy” rating and a $42.00 price target on the stock. JPMorgan Chase & Co. raised Smith & Nephew from a “neutral” rating to an “overweight” rating in a research report on Thursday, January 25th. Zacks Investment Research lowered Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Wednesday, October 4th. Finally, Morgan Stanley lowered Smith & Nephew from an “overweight” rating to an “equal weight” rating in a research report on Monday, December 11th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $44.00.

Smith & Nephew (NYSE:SNN) traded down $0.16 during trading on Monday, reaching $36.53. The company had a trading volume of 262,042 shares, compared to its average volume of 489,140. The company has a current ratio of 2.18, a quick ratio of 1.08 and a debt-to-equity ratio of 0.38. Smith & Nephew has a 12-month low of $29.76 and a 12-month high of $40.43.

Institutional investors and hedge funds have recently made changes to their positions in the business. Parametric Portfolio Associates LLC raised its position in shares of Smith & Nephew by 17.2% in the 3rd quarter. Parametric Portfolio Associates LLC now owns 516,794 shares of the medical equipment provider’s stock valued at $18,811,000 after purchasing an additional 76,003 shares in the last quarter. Crossmark Global Holdings Inc. acquired a new position in shares of Smith & Nephew in the 3rd quarter valued at approximately $12,640,000. Jane Street Group LLC raised its position in shares of Smith & Nephew by 109.1% in the 3rd quarter. Jane Street Group LLC now owns 340,327 shares of the medical equipment provider’s stock valued at $12,388,000 after purchasing an additional 177,546 shares in the last quarter. Blue Jay Capital Management LLC acquired a new position in shares of Smith & Nephew in the 2nd quarter valued at approximately $6,970,000. Finally, FDx Advisors Inc. raised its position in shares of Smith & Nephew by 39.5% in the 3rd quarter. FDx Advisors Inc. now owns 27,490 shares of the medical equipment provider’s stock valued at $1,001,000 after purchasing an additional 7,790 shares in the last quarter. 6.44% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: “FY2017 EPS Estimates for Smith & Nephew plc Reduced by Northcoast Research (NYSE:SNN)” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/01/31/fy2017-eps-estimates-for-smith-nephew-plc-snn-lowered-by-northcoast-research.html.

About Smith & Nephew

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Get a free copy of the Zacks research report on Smith & Nephew (SNN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply